Date: {{$ActivityAssignDate}}

Dear Dr. {{$doctorName}},


Subject: A Survey to assess epidemiology and Treatment Practices in Management of Melasma among Dermatologists in India


In India, pigmentation disorders cause psychosocial effects that can lead to repercussions on the quality of life. Pigmentary disorders were also reported in a study among 10.8% of adult patients attending dermatology clinic at a hospital in Western India. The common presentations were hyperpigmentation, melasma, indistinct pigmented macules and periorbital hyperpigmentation. The most common clinical diagnosis of facial melanoses is Melasma (chloasma). Protection from sunlight and depigmentation (skin lightening or brightening) is the first step towards a practical treatment approach. The current treatment option includes photoprotection by using sunscreen, topical compounds (like skin lightening/brightening agents), camouflage, bleaching agents, chemical peels, and laser and light therapies depending on skin type and condition.


This Survey has been undertaken to assess epidemiology and Treatment Practices in Management of Melasma among Dermatologists in India.


As you will be spending some extra time to give your feedback on the questionnaire based on your clinical experience, we offer to pay you by cheque a professional fee of Rs {{$contractAmount}}, on receiving the completed Survey Questionnaire Form from you.


We trust you and we are partners in promoting safe and effective drug therapy. In that spirit we hope you will consent to participate in this study. If you do, please sign and return the enclosed reply along with your visiting card for accuracy of records.

Yours truly,



Mr. Shailaysh Shanbbhag

Associate Vice president

Sales & Marketing

Sun Pharmaceutical Industries Ltd.